logo

Endo International Plc (ENDP)



Trade ENDP now with
  Date
  Headline
2/25/2021 4:34:37 PM Endo Q4 EPS $0.51 Vs. Loss $0.96 Year Ago
2/17/2021 4:17:57 PM Endo Adds Jennifer Chao To Board
2/17/2021 4:16:00 PM Endo Appoints Jennifer Chao To Board Of Directors
1/5/2021 8:38:54 AM Endo Ventures Enters Licensing Agreement For Paladin Labs To Commercialize Abaloparatide In Canada
1/5/2021 8:22:41 AM Radius Health Enters Definitive Agreements With Endo Ventures For Abaloparatide
1/5/2021 8:03:32 AM Endo Aesthetics Launches Unbranded Campaign Designed To Eliminate Shame And Misinformation Relating To Cellulite
1/4/2021 9:05:35 AM Par Pharmaceutical Begins Shipping First Authorized Generic Versions Of Mallinckrodt's Amitiza 8 Mcg And 24 Mcg Capsules
1/4/2021 9:03:05 AM Endo Unveils Authorized Generic Version Of Amitiza Capsules In The United States
12/2/2020 9:13:18 AM BioSpecifics Technologies Announces Successful Completion Of Its Acquisition By Endo
12/2/2020 8:48:09 AM Endo Completes Acquisition Of BioSpecifics Technologies
11/18/2020 8:03:00 AM Endo Reports Expiration Of HSR Waiting Period For BioSpecifics Tender Offer
11/5/2020 5:02:35 PM Endo International plc (ENDP) Has Raised Its 2020 Revenue Estimate To $2.75 - $2.80 Bln From $2.60 - $2.70 Bln
11/5/2020 4:55:25 PM Endo Q3 Loss/share $0.33 Vs. Loss $9.35 Year Ago
11/5/2020 7:34:26 AM Endo To Cut 560 Full-time Positions; Expects Cash Savings